Last reviewed · How we verify

Infective cystitis — Treatment Landscape & Competitive Intelligence

Infective cystitis (disease) competitive landscape: 5 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

5 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Infective cystitis, deduplicated by molecule. See the full disease page for line-of-therapy detail.

DrugGenericSponsorClassTargetLine of therapyFirst approval
Cystadane BETAINE Recordati Methylating Agent [EPC] 1996-01-01
Cipro ciprofloxacin Bayer AG Fluoroquinolone antibiotic DNA topoisomerase II, DNA gyrase subunit A, DNA gyrase subunit A 1987-10-22
Cystadane Cystadane Mayo Clinic
Ofloxacine Ofloxacine Assistance Publique - Hôpitaux de Paris Gamma-aminobutyric acid receptor subunit alpha-2, Histamine H3 receptor, Muscarinic acetylcholine receptor M1
Ciprofloxacine Ciprofloxacine Poitiers University Hospital DNA topoisomerase II, DNA gyrase subunit A, DNA gyrase subunit A

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

  1. · 3 drugs in Infective cystitis
  2. Assistance Publique - Hôpitaux de Paris · 1 drug in Infective cystitis
  3. Bayer AG · 1 drug in Infective cystitis
  4. Mayo Clinic · 1 drug in Infective cystitis
  5. Poitiers University Hospital · 1 drug in Infective cystitis
  6. Recordati · 1 drug in Infective cystitis

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Infective cystitis:

Cite this brief

Drug Landscape (2026). Infective cystitis — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/infective-cystitis. Accessed 2026-06-10.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing